ALK and non-small cell lung carcinoma: A total of 322 patients diagnosed with metastatic NSCLC harboring ALK rearrangements, confirmed by histopathological and imaging examinations, were identified between September 1, 2013, and August 30, 2024, with median follow-up for 52.8 months.